Annual ROA
-59.64%
+36.46%+37.94%
December 31, 2023
Summary
- As of February 7, 2025, FENC annual return on assets is -59.64%, with the most recent change of +36.46% (+37.94%) on December 31, 2023.
- During the last 3 years, FENC annual ROA has risen by +19.85% (+24.97%).
- FENC annual ROA is now -166.54% below its all-time high of 89.63%, reached on December 31, 2013.
Performance
FENC ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-2.39%
-9.31%-134.54%
September 30, 2024
Summary
- As of February 7, 2025, FENC quarterly return on assets is -2.39%, with the most recent change of -9.31% (-134.54%) on September 30, 2024.
- Over the past year, FENC quarterly ROA has dropped by -9.31% (-134.54%).
- FENC quarterly ROA is now -101.17% below its all-time high of 204.15%, reached on March 31, 2014.
Performance
FENC Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
FENC ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +37.9% | -134.5% |
| 3 y3 years | +25.0% | +97.9% |
| 5 y5 years | -54.9% | +97.9% |
FENC ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +37.9% | -126.3% | +97.9% |
| 5 y | 5-year | at high | +37.9% | -126.3% | +97.9% |
| alltime | all time | -166.5% | +76.0% | -101.2% | +99.4% |
Fennec Pharmaceuticals ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -2.39%(-134.5%) |
| Jun 2024 | - | 6.92%(-24.0%) |
| Mar 2024 | - | 9.10%(-112.9%) |
| Dec 2023 | -59.64%(-37.9%) | -70.32%(-18.2%) |
| Sep 2023 | - | -85.94%(-25.8%) |
| Jun 2023 | - | -115.79%(+1.2%) |
| Mar 2023 | - | -114.45%(+10.5%) |
| Dec 2022 | -96.10%(+49.1%) | -103.57%(+10.5%) |
| Sep 2022 | - | -93.71%(+20.0%) |
| Jun 2022 | - | -78.11%(+18.3%) |
| Mar 2022 | - | -66.02%(+3.4%) |
| Dec 2021 | -64.45%(-18.9%) | -63.87%(+16.6%) |
| Sep 2021 | - | -54.79%(-3.1%) |
| Jun 2021 | - | -56.53%(-15.0%) |
| Mar 2021 | - | -66.49%(-5.0%) |
| Dec 2020 | -79.49%(+15.4%) | -70.02%(-13.8%) |
| Sep 2020 | - | -81.19%(+12.4%) |
| Jun 2020 | - | -72.21%(-18.5%) |
| Mar 2020 | - | -88.55%(+26.8%) |
| Dec 2019 | -68.88%(+78.9%) | -69.82%(+17.6%) |
| Sep 2019 | - | -59.39%(+1.7%) |
| Jun 2019 | - | -58.39%(+29.2%) |
| Mar 2019 | - | -45.20%(+17.8%) |
| Dec 2018 | -38.51%(-11.5%) | -38.38%(-3.3%) |
| Sep 2018 | - | -39.71%(-8.7%) |
| Jun 2018 | - | -43.51%(-12.3%) |
| Mar 2018 | - | -49.62%(-21.4%) |
| Dec 2017 | -43.53%(-61.1%) | -63.13%(-31.5%) |
| Sep 2017 | - | -92.21%(+23.9%) |
| Jun 2017 | - | -74.42%(-17.8%) |
| Mar 2017 | - | -90.55%(-0.9%) |
| Dec 2016 | -111.76%(+187.5%) | -91.36%(+6.5%) |
| Sep 2016 | - | -85.79%(-4.7%) |
| Jun 2016 | - | -90.06%(-1.4%) |
| Mar 2016 | - | -91.32%(+140.1%) |
| Dec 2015 | -38.87%(-63.2%) | -38.04%(-149.8%) |
| Sep 2015 | - | 76.31%(-31.8%) |
| Jun 2015 | - | 111.95%(+39.4%) |
| Mar 2015 | - | 80.33%(-153.5%) |
| Dec 2014 | -105.53%(-217.7%) | -150.26%(-32.5%) |
| Sep 2014 | - | -222.64%(-43.2%) |
| Jun 2014 | - | -392.00%(-292.0%) |
| Mar 2014 | - | 204.15%(+71.1%) |
| Dec 2013 | 89.63%(-167.0%) | 119.35%(-136.8%) |
| Sep 2013 | - | -324.50%(+61.2%) |
| Jun 2013 | - | -201.30%(-47.6%) |
| Mar 2013 | - | -384.38%(+183.0%) |
| Dec 2012 | -133.83% | -135.82%(-228.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | 106.03%(+129.4%) |
| Jun 2012 | - | 46.22%(-16.8%) |
| Mar 2012 | - | 55.57%(-33.8%) |
| Dec 2011 | 82.60%(-136.0%) | 83.88%(-218.7%) |
| Sep 2011 | - | -70.65%(-3878.1%) |
| Jun 2011 | - | 1.87%(-103.7%) |
| Mar 2011 | - | -50.06%(-73.1%) |
| Dec 2010 | -229.21%(+162.3%) | -185.80%(+474.7%) |
| Sep 2010 | - | -32.33%(-74.1%) |
| Jun 2010 | - | -124.63%(+58.0%) |
| Mar 2010 | - | -78.87%(-33.1%) |
| Dec 2009 | -87.39%(-25.2%) | -117.97%(-15.4%) |
| Sep 2009 | - | -139.48%(-4.8%) |
| Jun 2009 | - | -146.44%(+10.0%) |
| Mar 2009 | - | -133.09%(+12.2%) |
| Dec 2008 | -116.89%(+4.3%) | -118.62%(+19.1%) |
| Sep 2008 | - | -99.56%(+19.5%) |
| Jun 2008 | - | -83.34%(+16.8%) |
| Mar 2008 | - | -71.34%(-5.6%) |
| Dec 2007 | -112.07%(+2.9%) | -75.55%(-20.4%) |
| Sep 2007 | - | -94.91%(-0.7%) |
| Jun 2007 | - | -95.54%(-0.5%) |
| Mar 2007 | - | -96.03%(+9.2%) |
| Dec 2006 | -108.93%(+98.6%) | -87.96%(+29.4%) |
| Sep 2006 | - | -67.99%(+8.7%) |
| Jun 2006 | - | -62.57%(+1.9%) |
| Mar 2006 | - | -61.42%(+10.8%) |
| Dec 2005 | -54.84%(+111.5%) | -55.42%(+38.1%) |
| Sep 2005 | - | -40.13%(+13.3%) |
| Jun 2005 | - | -35.42%(+24.8%) |
| Mar 2005 | - | -28.39%(+3.4%) |
| Sep 2004 | - | -27.45%(+4.9%) |
| Jun 2004 | -25.93%(-31.5%) | -26.17%(-5.5%) |
| Mar 2004 | - | -27.69%(0.0%) |
| Dec 2003 | - | -27.69%(-13.0%) |
| Sep 2003 | - | -31.83%(-10.2%) |
| Jun 2003 | -37.85%(-12.1%) | -35.46%(-11.7%) |
| Mar 2003 | - | -40.17%(-7.7%) |
| Dec 2002 | - | -43.51%(-17.6%) |
| Sep 2002 | - | -52.79%(+20.3%) |
| Jun 2002 | -43.06%(-2.6%) | -43.90%(+31.6%) |
| Mar 2002 | - | -33.35%(-0.5%) |
| Dec 2001 | - | -33.51%(+0.6%) |
| Sep 2001 | - | -33.32%(+9.8%) |
| Jun 2001 | -44.23%(-82.2%) | -30.35%(+1.1%) |
| Mar 2001 | - | -30.03%(+72.8%) |
| Dec 2000 | - | -17.38% |
| Jun 2000 | -248.34% | - |
FAQ
- What is Fennec Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals annual ROA year-on-year change?
- What is Fennec Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals quarterly ROA year-on-year change?
What is Fennec Pharmaceuticals annual return on assets?
The current annual ROA of FENC is -59.64%
What is the all time high annual ROA for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual return on assets is 89.63%
What is Fennec Pharmaceuticals annual ROA year-on-year change?
Over the past year, FENC annual return on assets has changed by +36.46% (+37.94%)
What is Fennec Pharmaceuticals quarterly return on assets?
The current quarterly ROA of FENC is -2.39%
What is the all time high quarterly ROA for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly return on assets is 204.15%
What is Fennec Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, FENC quarterly return on assets has changed by -9.31% (-134.54%)